Shariah PSXMember desk · PSX
Start trial
CorporateNegative · Do not buyPSX

LIVEN: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations

Liven Pharma Limited — Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations

Full article on PSX

Share

LIVEN: Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations — Pharma, Markets | Shariah PSX

Desk Analysis

How This Affects the Exchange

Sector Effect

Negative · Do not buy

Cautious read for Pharma, Markets — price/volume reaction may stay soft near-term.

Sectors & Direction

Desk read

Desk call: Do not buy · Negatively affected

  • PharmaNegatively affected
  • MarketsNegatively affected

Companies

LIVEN · Do not buy

Companies Mentioned

  • · Negatively affected · Do not buy

Mentions in This Briefing

Sectors: Pharma, Markets — Negative · Do not buy. PSX tickers: LIVEN. Cautious read for Pharma, Markets — price/volume reaction may stay soft near-term.

Full Story

Open on PSX

Liven Pharma Limited — Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations

Desk note

Shariah (KMI) company announcement — Insider. Use as a long-term entry / exit context signal for LIVEN; not a trade instruction.

Source

Open on PSX